BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 16474158)

  • 1. Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1.
    Moore PL; Crooks ET; Porter L; Zhu P; Cayanan CS; Grise H; Corcoran P; Zwick MB; Franti M; Morris L; Roux KH; Burton DR; Binley JM
    J Virol; 2006 Mar; 80(5):2515-28. PubMed ID: 16474158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrete partitioning of HIV-1 Env forms revealed by viral capture.
    Stieh DJ; King DF; Klein K; Aldon Y; McKay PF; Shattock RJ
    Retrovirology; 2015 Sep; 12():81. PubMed ID: 26399966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV type 1 Env precursor cleavage state affects recognition by both neutralizing and nonneutralizing gp41 antibodies.
    Chakrabarti BK; Pancera M; Phogat S; O'Dell S; McKee K; Guenaga J; Robinson J; Mascola J; Wyatt RT
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):877-87. PubMed ID: 21158699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120.
    Crooks ET; Moore PL; Franti M; Cayanan CS; Zhu P; Jiang P; de Vries RP; Wiley C; Zharkikh I; Schülke N; Roux KH; Montefiori DC; Burton DR; Binley JM
    Virology; 2007 Sep; 366(2):245-62. PubMed ID: 17580087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies.
    Poignard P; Moulard M; Golez E; Vivona V; Franti M; Venturini S; Wang M; Parren PW; Burton DR
    J Virol; 2003 Jan; 77(1):353-65. PubMed ID: 12477840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 ENVELOPE. Effect of the cytoplasmic domain on antigenic characteristics of HIV-1 envelope glycoprotein.
    Chen J; Kovacs JM; Peng H; Rits-Volloch S; Lu J; Park D; Zablowsky E; Seaman MS; Chen B
    Science; 2015 Jul; 349(6244):191-5. PubMed ID: 26113642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric Structures and Conformational Plasticity of the Uncleaved Full-Length Human Immunodeficiency Virus Envelope Glycoprotein Trimer.
    Zhang S; Wang K; Wang WL; Nguyen HT; Chen S; Lu M; Go EP; Ding H; Steinbock RT; Desaire H; Kappes JC; Sodroski J; Mao Y
    J Virol; 2021 Nov; 95(24):e0052921. PubMed ID: 34549974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme digests eliminate nonfunctional Env from HIV-1 particle surfaces, leaving native Env trimers intact and viral infectivity unaffected.
    Crooks ET; Tong T; Osawa K; Binley JM
    J Virol; 2011 Jun; 85(12):5825-39. PubMed ID: 21471242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design.
    Parren PW; Gauduin MC; Koup RA; Poignard P; Fisicaro P; Burton DR; Sattentau QJ
    Immunol Lett; 1997 Jun; 57(1-3):105-12. PubMed ID: 9232434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design".
    Parren PW; Gauduin MC; Koup RA; Poignard P; Sattentau QJ; Fisicaro P; Burton DR
    Immunol Lett; 1997 Jul; 58(2):125-32. PubMed ID: 9271324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of polyclonal and monoclonal anti-glycoprotein 120 antibodies with oligomeric glycoprotein 120-glycoprotein 41 complexes of a primary HIV type 1 isolate: relationship to neutralization.
    Fouts TR; Trkola A; Fung MS; Moore JP
    AIDS Res Hum Retroviruses; 1998 May; 14(7):591-7. PubMed ID: 9591713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion.
    Finnegan CM; Berg W; Lewis GK; DeVico AL
    J Virol; 2002 Dec; 76(23):12123-34. PubMed ID: 12414953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: oligomer-specific and -sensitive monoclonal antibodies.
    Broder CC; Earl PL; Long D; Abedon ST; Moss B; Doms RW
    Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11699-703. PubMed ID: 7972127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV. The modern era of HIV-1 vaccine development.
    Mascola JR
    Science; 2015 Jul; 349(6244):139-40. PubMed ID: 26160931
    [No Abstract]   [Full Text] [Related]  

  • 15. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
    Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
    Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic properties of the HIV envelope on virions in solution.
    Ray K; Mengistu M; Yu L; Lewis GK; Lakowicz JR; DeVico AL
    J Virol; 2014 Feb; 88(3):1795-808. PubMed ID: 24284318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and structural analysis of soluble oligomeric gp140 envelope proteins derived from neutralization-resistant and neutralization-susceptible primary HIV type 1 isolates.
    Stamatatos L; Lim M; Cheng-Mayer C
    AIDS Res Hum Retroviruses; 2000 Jul; 16(10):981-94. PubMed ID: 10890360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the multiple conformational States of free monomeric and trimeric human immunodeficiency virus envelope glycoproteins after fixation by cross-linker.
    Yuan W; Bazick J; Sodroski J
    J Virol; 2006 Jul; 80(14):6725-37. PubMed ID: 16809278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covalently linked human immunodeficiency virus type 1 gp120/gp41 is stably anchored in rhabdovirus particles and exposes critical neutralizing epitopes.
    McKenna PM; Pomerantz RJ; Dietzschold B; McGettigan JP; Schnell MJ
    J Virol; 2003 Dec; 77(23):12782-94. PubMed ID: 14610200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purified complexes of HIV-1 envelope glycoproteins with CD4 and CCR5(CXCR4): production, characterization and immunogenicity.
    Xiao X; Phogat S; Shu Y; Phogat A; Chow YH; Wei OL; Goldstein H; Broder CC; Dimitrov DS
    Vaccine; 2003 Oct; 21(27-30):4275-84. PubMed ID: 14505910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.